Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Affirm Holdings Inc (AFRM) vs Novo Nordisk A/S (NVO) Price & Performance

Affirm Holdings IncTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Affirm Holdings Inc vs Novo Nordisk A/S — how do they compare? Affirm Holdings Inc trades at $77.35 (market cap $25.69B), while Novo Nordisk A/S trades at $45.75 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 8.1× Affirm Holdings Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.

AFRMNVO
Market Cap
$25.69B$207.85B
Sector
FinancialsHealth
52-Week High
$92.18$63.98
52-Week Low
$42.53$35.29
Enterprise Value
$32.30B$222.55B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Affirm Holdings Inc

Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.

Read more on AFRM

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO